Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer.
Pharmaceuticals (Basel). 2023 May 12;16(5):735. doi: 10.3390/ph16050735.
Pharmaceuticals (Basel). 2023.
PMID: 37242518
Free PMC article.
GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models.
Guo S, Zhang C, Mottamal M, Hossain A, Liu J, Wang G.
Guo S, et al.
Breast Cancer Res Treat. 2020 Apr;180(2):359-368. doi: 10.1007/s10549-020-05558-w. Epub 2020 Feb 6.
Breast Cancer Res Treat. 2020.
PMID: 32030569
Free PMC article.
Item in Clipboard
Design, Synthesis, and Antitumor Activity of a Series of Novel 4-(Aromatic Sulfonyl)-1-oxa-4-azaspiro[4.5]deca-6,9-dien-8-ones.
Xing N, Chen C, Zhong Q, Zheng S, Wang G, He L.
Xing N, et al.
Molecules. 2020 Nov 21;25(22):5459. doi: 10.3390/molecules25225459.
Molecules. 2020.
PMID: 33233396
Free PMC article.
Item in Clipboard
Cite
Cite